The Parkinson’s Disease-Associated H50Q Mutation Accelerates α-Synuclein Aggregation in Vitro

Citations Over TimeTop 10% of 2013 papers

Abstract

α-Synuclein (α-Syn) aggregation is directly linked with Parkinson's disease (PD) pathogenesis. Here, we analyzed the aggregation of newly discovered α-Syn missense mutant H50Q in vitro and found that this mutation significantly accelerates the aggregation and amyloid formation of α-Syn. This mutation, however, did not alter the overall secondary structure as suggested by two-dimensional nuclear magnetic resonance and circular dichroism spectroscopy. The initial oligomerization study by cross-linking and chromatographic techniques suggested that this mutant oligomerizes to an extent similar to that of the wild-type α-Syn protein. Understanding the aggregation mechanism of this H50Q mutant may help to establish the aggregation and phenotypic relationship of this novel mutant in PD.

Related Papers

• → Chediak–Higashi syndrome: description of two novel homozygous missense mutations causing divergent clinical phenotype(2013)28 cited
• → Identification and molecular characterisation of a homozygous missense mutation in the ADAMTS10 gene in a patient with Weill–Marchesani syndrome(2014)20 cited
• → Characterization ofp53 mutants identified in human tumors with a missense mutation in the tetramerization domain(1998)27 cited
• → In vitro characterization of missense mutations associated with quantitative protein S deficiency(2006)14 cited
• → FAIM Opposes Aggregation of Mutant SOD1 That Typifies Some Forms of Familial Amyotrophic Lateral Sclerosis(2020)12 cited